tapebrief
XYL · Q2 2025
Preliminary brief— based on press release only. Full analysis including management tone and Q&A will be added when the transcript is available.

XYL · Q3 2025 Earnings

Xylem Inc.

Reported October 28, 2025

30-second summary

Xylem delivered $2.27B revenue (+7.8% YoY, +7% organic) and adjusted EPS of $1.37 — $0.12 above the high end of the Q2-issued Q3 guide — with adjusted EBITDA margin of 23.2%, a full 100bps above the prior guide ceiling. Management raised FY2025 adjusted EPS to $5.03–$5.08 (midpoint up 28 cents from $4.775), tightened revenue to exactly $9.0B, and lifted the FY EBITDA margin band by 70–90bps to 22.0–22.3%. The Q4 guide implies organic growth decelerating to 2–3% from Q3's 7%, but that is more an artifact of last year's Q4 comp and conservative phasing than a demand signal — the FY raise is the news.

Headline numbers

EPS

Q3 FY2025

$1.37

Revenue

Q3 FY2025

$2.27B

+7.8% YoY

Gross margin

Q3 FY2025

38.9%

Operating margin

Q3 FY2025

14.7%

Key financials

Q3 FY2025
MetricQ3 FY2025YoYQ2 FY2025QoQ
Revenue$2.27B+7.8%$2.30B-1.4%
EPS$1.37—$1.26+8.7%
Gross margin38.9%—38.8%+10bps
Operating margin14.7%—13.3%+140bps

Guidance

Guidance is issued for the full year only, refreshed each quarter. Prior and new below are the same FY updated this quarter.

Actuals vs prior guidance

MetricPeriodPrior guideActualΔResult
EPS (non-GAAP)Q3 FY2025$1.20 to $1.25$1.37+$0.12 above guide highBeat
Organic Revenue GrowthQ3 FY20254% to 5%7%+200 bps above guide highBeat
Adjusted EBITDA MarginQ3 FY202520.7% to 22.2%23.2%+100 bps above guide highBeat

New guidance

MetricPeriodGuideYoY
RevenueQ4 FY2025approximately $2.4B—
Organic Revenue GrowthQ4 FY20252% to 3%—

Changes to prior guidance

MetricPeriodPrior guideNew guideΔResult
Revenue
FY2025
$8.9B to $9.0B$9.0Bmidpoint raised from $8.95B to $9.0B; low end raised from $8.9B to $9.0BRaised
Revenue Growth (Reported Basis)
FY2025
4% to 5%5% to 6%+100 bps at both endsRaised
Revenue Growth (Organic Basis)
FY2025
approximately 4%4% to 5%+100 bps at high endRaised
Adjusted EBITDA Margin
FY2025
21.3% to 21.8%22.0% to 22.3%+70 to +90 bpsRaised
Adjusted EBITDA Margin Expansion vs 2024
FY2025
70 to 120 basis points140 to 170 basis points+70 bps at both endsRaised
EPS (non-GAAP)
FY2025
$4.70 to $4.85$5.03 to $5.08+$0.23 to +$0.38; midpoint raised from $4.775 to $5.055Raised

Reaffirmed unchanged this quarter: Free Cash Flow Margin (9% to 10%)

Segment KPIs

Q3 FY2025
SegmentQ3 FY2025YoY
Water Infrastructure$0.656B+5.3%
Applied Water$0.456B+2.0%
Measurement and Control Solutions$0.522B+13.9%
Water Solutions and Services$0.634B+10.1%
Measurement and Control Solutions Organic Growth11%—
Water Solutions and Services Organic Growth10%—

Other KPIs

Q3 FY2025
SegmentQ3 FY2025
Adjusted EBITDA Margin23.2%
Adjusted EBITDA Margin YoY Expansion+200 bps
Organic Revenue Growth7%
Net Income Margin10.0%
FY2025 Adjusted EPS Guidance$5.03–$5.08
FY2025 Adjusted EBITDA Margin Guidance22.0–22.3%

Management tone

Q1 anchor → Q2 anchor → Q3 anchor: 80-20 as cost program → 80-20 as proof point → 80-20 as cultural operating model.

Simplification reframed from program to permanent operating model. A quarter ago the 80-20 narrative had moved from bet to proof, with on-time performance metrics showing up alongside financials. This quarter the framing escalates again: "80-20 isn't a cost-out tool. It's about resource allocation… from a tool set to more of a critical piece on how we run the business, which is, in my mind, more cultural." When CEOs start describing an initiative as cultural rather than operational, they're signaling they no longer think investors should model it as a discrete margin bucket — it's the baseline.

Guidance posture flipped from disciplined raise to explicit declaration of conservatism. Q2's raise was framed as warranted by execution; this quarter management volunteered that the February starting point was conservative: "we have confidence in our ability to meaningfully outperform our initial guidance set out in February." Companies do not typically advertise that their own prior guide was too low unless they are signaling that more raises are likely.

China escalated from de-emphasis to structural surgery. Q2 called out China orders down ~18% YoY and tied it to deliberate portfolio pruning. This quarter the cut is quantified and immediate: "We're taking restructuring actions as we speak in China to the extent of around 40% of the workforce is coming out." This converts a soft "walking away" narrative into a hard cost action with P&L impact.

Portfolio optimization shifted from passive to active divestiture. Last quarter's M&A discipline talk was directional; this quarter management announced divestiture of the international metering business with a quantified rationale: "This will drive a 100 basis point margin improvement in the MCS segment on a run rate basis." MCS just printed 13.9% growth — divesting the dilutive piece of a winning segment is an aggressive use of the simplification dividend.

Multi-phase journey articulated for the first time. Pine introduced an explicit three-phase framework: phase one (simplification, now executing), phase two ("leverage that simplification… to drive our growth engine"), phase three ("long-term competitiveness"). Translating the cost story into a multi-year growth roadmap is the kind of narrative shift that typically precedes investor-day rebases.

Recurring themes management leaned on this quarter:

80-20 simplification embedding as cultural operating model, not temporary cost programAcceleration of structural benefits beyond initial guidance frameworkAI infrastructure as macro tailwind for water solutions (data centers, chip fabrication, mining)Resilient municipal and industrial demand offsetting China contractionPortfolio optimization through selective divestiture and M&A disciplineCustomer-centric service improvements (on-time delivery, quality) as margin and retention lever

Risks management surfaced:

Tariffs ($180 million annualized impact with 'slight margin dilutive effect' despite pricing offsets)China demand contraction and hyper-competitiveness requiring structural workforce reductionMacro uncertainty including FX movements and government shutdown impacts on federal fundingTiming of capital project conversion from commercial funnel to orders taking longer than normalSupply chain execution risks given outsourced water projects and restructuring costs pressuring year-to-date FCF

Answers to last quarter's watch list

MCS book-to-bill flips positive by year-end — MCS posted +13.9% reported / +11% organic growth in Q3, with management announcing divestiture of the international metering business to concentrate on AMI. The book-to-bill metric itself wasn't directly quantified on the print, but the +200bps acceleration in organic growth versus Q2 and the structural portfolio action both point toward the year-end inflection management committed to.
Continue monitoring
Applied Water margin durability — Applied Water revenue decelerated to +2% YoY from Q2's +6%, the slowest segment growth in the portfolio. The "two-thirds structural" margin claim wasn't directly tested this quarter at the segment-margin line (segment-level margins were not parsed in the release commentary), but the sharp growth deceleration calls into question the segment's recent role as 80-20 template.
Resolved negatively
Q3 adjusted EBITDA margin range of 20.7%–22.2% — Delivered 23.2%, fully 100bps above the high end. The "low-end implies compression" risk did not materialize; the print was the strongest quarterly EBITDA margin in the dataset, and Q4 is now guided to ~23% — sustained, not a one-quarter spike.
Resolved positively
China orders trajectory — Management is now extracting 40% of the China workforce via restructuring. China contraction continues, but management is converting it from a revenue drag into a margin event with quantified action. Status: Resolved negatively on demand, Resolved positively on management response
UK AMP cycle and Canada municipal timing — Not explicitly addressed in the release commentary. With reported organic growth of 7% and Water Infrastructure +5.3%, any second-half snapback appears to be unfolding broadly in line with management's Q2 framing, but no granular update was disclosed.
Continue monitoring
Tariff dilution magnitude — Now quantified: $180M annualized impact with "slight margin dilutive effect" despite pricing offsets, with management still flagging "uncertainty around final timing and tariff levels." The fact that 23.2% EBITDA margin was delivered net of this drag is the real read.
Resolved positively

What to watch into next quarter

Q4 organic growth of 2–3% guide vs Q3's 7% print — management framed the deceleration via tougher comps, but a Q4 organic print at or below 2% would suggest the underlying demand story has softened more than the FY raise implies

FY2026 initial guide framing — given the explicit "meaningfully outperform initial guidance" comment, watch whether management starts FY26 with a wider range or a more confident point estimate, signaling whether the multi-year simplification flywheel is being underwritten in forward modeling

International metering divestiture timing and proceeds — management quantified a 100bps MCS margin uplift on close; track announced timing, after-tax proceeds, and capital deployment intentions

China restructuring charges and FY26 run-rate savings — 40% workforce reduction will carry charges; the question is when run-rate savings hit and how big they are versus the remaining China revenue base

Free cash flow margin holding 9–10% with FCF reaffirmed unchanged — given EPS guide raised by ~6% at midpoint, the unchanged FCF margin guide implies either conservative FCF phasing or restructuring cash costs absorbing the earnings upside; YTD FCF disclosure in the 10-Q will clarify

Phase two ("growth engine") evidence — management introduced a multi-phase framework; watch for early M&A pipeline color or commercial investment disclosures in Q4 or at any investor day signaling phase-two capital deployment

Sources

  1. Xylem Inc. Q3 FY2025 earnings press release (Form 8-K Exhibit 99.1), filed October 28, 2025 — https://www.sec.gov/Archives/edgar/data/1524472/000152447225000043/xyl10282025ex991.htm
  2. Xylem Q3 FY2025 earnings call commentary — prepared remarks (Pine, Grogan) on FY guidance raise, 80-20 transformation phases, China restructuring, and international metering divestiture

Get the next brief, free.

We publish analyst-grade earnings briefs the same day or morning after every call — headline numbers, segment KPIs, Q&A highlights, and tone analysis. Free during beta.

This is not investment advice.